November 30, 2006 (Chicago) -- Magnetic resonance spectroscopic imaging (MRSI) shows no advantages over magnetic resonance imaging (MRI) alone for localization of peripheral zone prostate cancer in ...
MRS has been used to characterize cancerous lesions in widely divergent parts of the body. In the breast, researchers at Memorial Sloan-Kettering Cancer Center have shown that adding MRS sequences to ...